cell in Medical News

U.S. Stem Cell Research Seems to Focus on Two Lines

Experts urge federal government to preserve study options FRIDAY, Aug. 7 (HealthDay News) -- Only two of 21 approved human embryonic stem cell lines are routinely used by researchers in the United States, says a new study. The study found that two cell lines, known as H1 and H9, ac...

Live recordings of cell communication

Neurons communicate with each other with the help of nano-sized vesicles. Disruption of this communication process is responsible for many diseases and mental disorders like e.g. depression. Nerve signals travel from one neuron to another through vesicles - a nano-sized container loaded with neuro...

Sperm Cell Insights May Aid Stem Cell Research

Scientists spot proteins that help sperm revert to stem cell state THURSDAY, Aug. 6 (HealthDay News) -- Two proteins that play a major role in reverting adult sperm cells back into stem cells have been identified by U.S. researchers. A team from Johns Hopkins University School of Me...

Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum

OLDSMAR, Fla., Aug. 6 /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation, will present data on the proliferative ability of stem cells found in menstrual blood (known as Men...

Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations

RIDGEFIELD, Conn., Aug. 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International Association for the Study of Lung Cancer's 13th World Conference on Lung Cancer (WCLC), San Francisco, CA, the initiation of a Phase III clinical study of BIBW 2992 as first-line treatment...

AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer

WILMINGTON, Del., July 30 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for an inves...

'Artificial Golgi' may provide new insight into key cell structure

Scientists in New York and North Carolina are reporting assembly of the first functioning prototype of an artificial Golgi organelle. That key structure inside cells helps process and package hormones, enzymes, and other substances that allow the body to function normally. The lab-on-a-chip device...

Viagra Trial for Sickle Cell Lung Problems Halted

Safety concern from side effects prompts action by U.S. government TUESDAY, July 28 (HealthDay News) -- The first clinical trial of a treatment for pulmonary hypertension in adults with sickle cell anemia has been stopped because of severe side effects in some participants. The tria...

NHLBI stops study of pulmonary hypertension treatment in sickle cell patients

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns. In an interim review of safety data from 33 p...

Bcl6 gene sculpts helper T cell to boost antibody production

HOUSTON - Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists at The University of Texas M. D. Anderson Cancer Center r...

Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration

Growth factor enhances heart regeneration, improves heart function without need for cardiac stem cells (Vocus) July 16, 2009 -- Injured heart tissue normally can't regrow, but researchers at Children's Hospital Boston have now laid the groundwork for regenerating hear...

World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial

Infusion Procedure Performed on July 17th LOUISVILLE, Ky., July 23 /PRNewswire-USNewswire/ -- University of Louisville physicians performed the world's first cardiac adult stem cell infusion procedure at Jewish Hospital in Louisville, KY, on July 17, 2009. The procedure i...

Critical link in cell death pathway revealed

The role of a protein called XIAP in the regulation of cell death has been identified by Walter and Eliza Hall Institute researchers and has led them to recommend caution when drugs called IAP inhibitors are used to treat cancer patients with underlying liver conditions. A team led by Professor ...

Eliminating Cell Receptor Prevents Infections in Animal Study

PHILADELPHIA, July 22 /PRNewswire-USNewswire/ -- New research from The Children's Hospital of Philadelphia sheds light on the role of cell receptors in acting as gatekeepers for infectious viruses. By using mice genetically engineered to lack a particular receptor in heart and pancreas c...

More Americans Have Cell Phones Than Dental Coverage

PORTLAND, Ore. July 20 /PRNewswire/ -- Studies link poor oral health with a higher risk for heart disease, stroke, and delivery of premature or low birth-weight babies. Despite these documented risks, 45 percent of the U.S. population is living without dental insurance - nearly ...

Stem Cell Decision Opens New Doors, May Spur More Research

Some avenues of scientific inquiry remain unfunded, however,, WEDNESDAY, July 15 (HealthDay News) -- The U.S. National Institutes of Health (NIH) announced last week their new guidelines for stem cell research funding, including allowing some previously ineligible stem cell lines to re...

Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions

Global agreement strengthens customized manufacturing solutions for upstream and downstream processing and moves the 'disposable factory' closer to reality GOETTINGEN, Germany and ST. LOUIS, July 14 /PRNewswire-FirstCall/ -- Sartorius Stedim Biotech (Euronext: DIM), and SAFC B...

Cord Blood America Hires Management Team for Its New Stem Cell Laboratory

SANTA MONICA, Calif. and LAS VEGAS, July 10 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells t...

Cord Blood America Leases Las Vegas Building for Its Own Stem Cell Laboratory

SANTA MONICA, Calif. and LAS VEGAS, July 9 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to...

Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, Inc. (LFA) is accepting letters of intent until July 13 for grants to advance adult stem cell transplantation research in humans as a treatment for lupus, and to better understand pediatric lupus features and societal f...

Cerebral Palsy Improves After Bone Marrow Stem Cell Procedure

MISSION VIEJO, Calif., July 8 /PRNewswire/ -- Dr. David Steenblock of Mission Viejo, California, a pioneer in clinical applications of stem cells, is pleased to report the results of a 16 year old girl who suffered from cerebral palsy. The patient had right side paralysis and spasticity since birt...

Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, Chairman of the U.S. Catholic Bishops' Committee on Pro-Life Activities, reacted today to final guidelines for human embryonic stem cell research issued yesterday by the National Institutes of Health (NIH). The text of his state...

NIH Stem Cell Guidelines Ethically Irresponsible, Scientifically Unworthy, Useless to Patients, Says Family Research Council

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) guidelines implementing President Obama's executive order for federal funding of human embryonic stem cell research (ESCR). President Obama's ...

European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.'s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application

SEATTLE, July 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it had requested and the EMEA has agreed to an oral explanation in support of the OPAXIO Marketing Authorization Application (MAA) in September, 2009 extending the review for the C...

Final Rules Broaden Pool for Stem Cell Research

Older stem cell lines eligible for U.S. research dollars, NIH says MONDAY, July 6 (HealthDay News) -- The U.S. government issued final guidelines Monday describing which embryonic stem cell lines will be eligible for government funding, effectively expanding the universe of stem cells ...

Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood

OLDSMAR, Fla., July 6 /PRNewswire-FirstCall/ -- Mercedes Walton, CEO of Cryo-Cell International, one of the largest and most established family cord blood banks, is praising legislative progress to date and encouraging continued momentum for existing bills through the second half of the year. ...

Master Stem Cell for Human Heart Identified

Researchers say it may hold key to understanding how to repair the organ WEDNESDAY, July 1 (HealthDay News) -- For the first time, researchers have identified a single "master" stem cell in humans that is capable of differentiating into all three major cell types that make up the human...

Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration

LA JOLLA, Calif., July 1 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has acquired exclusive intellectual property rights covering small molecule compositions and methods for inducing bone formation from The Regents of the University of California . These proprietary osteo...

Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration

Stemedica Cell Technologies, Inc., a leader in the manufacturing and development of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and r...

Al Copeland Day Lives on Through Efforts To Cure Merkel Cell Carcinoma

20th Anniversary of Al Copeland Day Honored with $150K Donation to the University of Pittsburgh Cancer Institute NEW ORLEANS, June 30 /PRNewswire/ -- After losing a battle to Merkel Cell Carcinoma, an aggressive and deadly form of skin cancer, the memory of Al Copeland will be honored t...

State's Good Government Agency Calls for Reforms at Stem Cell Agency

Key 'Little Hoover' Recommendations Follow Consumer Watchdog's Proposals SANTA MONICA, Calif., June 26 /PRNewswire-USNewswire/ -- California's good government agency, The Little Hoover Commission, today called for management and structural reforms at the state stem cell agency after an eight-...

Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine

Funding supports multiple commercial, emerging and pilot projects CLEVELAND, June 25 /PRNewswire-USNewswire/ -- The Center for Stem Cell & Regenerative Medicine (CSCRM), comprised of Case Western Reserve University (CWRU), Cleveland Clinic (CC), University Hospitals (UH), and Athersys, ...

Living Cell Technologies' Diabetes Clinical Trial Authorized by New Zealand Government

SYDNEY and AUCKLAND, New Zealand, June 24 /PRNewswire/ -- Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that the New Zealand Minister of Health, the Honourable Tony Ryall, has authorized LCT's New Zealand Phase I/IIa clinical trial of DIABECELL(R) for insulin dependent ...

Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors

Published study shows young donors experience a lower rate of adverse reactions on automated 2-unit red cell collection systems LAKE ZURICH, Ill., June 23 /PRNewswire/ -- Fenwal Inc. announced today it is hosting a live, online lecture by Richard J. Benjamin, M.D., Ph.D., chief medical offi...

Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) is seeking proposals for grant funding for research studies on lupus, an unpredictable and potentially fatal autoimmune disease. Grants will support areas of study in pediatric lupus and adult stem cell transplant...

Ruben Studdard, American Idol Winner and R&B Pop Star, Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload

National tour kicks-off June 19 at the United Nations NEW YORK, June 17 /PRNewswire/ -- Event Highlights: Performance by Ruben Studdard, including the world premiere of "I Am a Fighter," a song inspired by Be Sickle Smart United Nations declaration of Wor...

LA County Calls for Repeal of Federal Cell Tower Health Preemption

RESIDENTS SAY 'ENOUGH IS ENOUGH!' AS SUPERVISORS TAKE A STAND LOS ANGELES, June 16 /PRNewswire-USNewswire/ -- The Los Angeles County Board of Supervisors voted unanimously in early June to actively seek and support federal legislation to repeal portions of the Telecommunications Act of 1996 t...

Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer

Epidermal Growth Factor Receptor Mutation Test May Be Key To Identifying Patient Response to Drug Therapies ALISO VIEJO, Calif., June 16 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing services resource for pathologists, oncologis...

Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies

SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- Dr. Steven Josephs, Ph.D., a former National Cancer Institute (NCI) researcher, has joined Entest BioMedical Inc.'s ( www.entestbio.com ) Science Advisory Board where he will focus on expanding the company's stem cell cancer research. Dr. Josephs' NCI...

Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer

RARITAN, N.J., June 4 /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., today announced that it has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), with S...